Lotte Westerink

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Systemic Sclerosis

Health Insurance

Top Venues

The European journal of health economics : HEPAC : health economics in prevention and care

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Lotte Westerink, Sharon Wolters, Guiling Zhou, Arjan Postma, Cornelis Boersma, Job Frank Martien van Boven, Maarten Jacobus Postma
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade. The European journal of health economics : HEPAC : health economics in prevention and care (2024)
Lotte Westerink, Jelmer Lennart Jens Nicolai, Maarten Jacobus Postma, Job Frank Martien van Boven, Cornelis Boersma
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD). PharmacoEconomics - open 6 (5) (2022)
Lotte Westerink, Jelmer L J Nicolai, Carl Samuelsen, Hans J M Smit, Pieter E Postmus, Ingolf Griebsch, Maarten J Postma
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations. The European journal of health economics : HEPAC : health economics in prevention and care 21 (6) (2020)